Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T64271 | MAO-B-IN-6 | ||
MAO-B-IN-6 是一种选择性的、有效的、口服具有活力的 MAO-B 抑制剂 (IC50: 0.019 μM)。MAO-B-IN-6 在体内外的效果均优于 Safinamide。MAO-B-IN-6 具有潜力进行帕金森病 (PD) 的研究。 | |||
T38034 |
MAO-IN-M30 dihydrochloride
M 30 dihydrochloride |
Monoamine Oxidase | Neuroscience |
MAO-IN-M30 dihydrochloride (M 30 dihydrochloride) 是一种口服活性,可通过血脑屏障的,脑选择性不可逆 MAO-A (IC50=37 nM) 和 MAO-B (IC50=57 nM) 抑制剂。MAO-IN-M30 dihydrochloride 是有效的铁螯合剂、自由基清除剂。MAO-IN-M30 dihydrochloride 对 Dexamethasone 诱导的脑细胞凋亡具有神经保护作用。MAO-IN-M30 dihydrochloride 在 MPTP 和 lactacystin 帕金森病模型中也显示出神经恢复活性。 | |||
T36903 |
Rasagiline-13C3 (mesylate)
Rasagiline-13C3 (mesylate) |
||
Rasagiline-13C3is intended for use as an internal standard for the quantification of rasagiline by GC- or LC-MS. Rasagiline is an inhibitor of monoamine oxidase B (MAO-B; IC50= 4.43 nM for the rat brain enzyme).1It is selective for MAO-B over MAO-A (IC50= 412 nM for the rat brain enzyme). It inhibits serum and NGF withdrawal-induced apoptosis of PC12 cells when used at concentrations ranging from 0.01 to 100 μM.2Rasagiline inhibits rat brain MAO-Bin vivo(ED50= 0.1 mg/kg).1It reduces cerebral ede... |